Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (12): 46-51.doi: 10.6040/j.issn.1671-7554.0.2019.886

Previous Articles    

Biological effects of ubenimex on ovarian cancer A2780 cell

GUAN Hongwei, LI Juan, SUN Rui, LIU Jie, LI Changzhong   

  1. Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Published:2022-09-27

PDF (PC)

8

Abstract: Objective To investigate the effect of ubenimex on cell proliferation, cell cycle, apoptosis, autophagy, migration and invasion in ovarian cancer A2780 cell and its possible mechanism. Methods CCK-8 assay was used to analyze the effect of ubenimex on proliferation of A2780 cell. Transwell assay was performed to detect the effect of ubenimex on migration and invasion of A2780 cell. Flow cytometry was used to analyze the cell apoptosis and cell cycle. Western blotting was performed to investigate the protein expression levels of APN, AKT, p-AKT, LC3-B, and p62. Results (1)Ubenimex inhibited A2780 cell proliferation(Fconcentration=812.56,P<0.001;Ftime=8.58,P=0.010;Fconcentration×time=4.00,P=0.027), migration(t=56.9, P<0.001)and invasion(t=11.8, P<0.001), increased the cell proportion in G2/M phase (t=7.9, P=0.016)and decreased the cell proportion in G1 phase (t=14.8, P=0.005)which led to G2/M cell cycle arrest. (2)Ubenimex induced A2780 cell apoptosis(P=0.002), and cell apoptosis was increased when ubenimex was combined with AKT inhibitor(P=0.007). (3)Ubenimex reduced the APN expression, but increased p-AKT, LC3B and p62 expressions. Conclusion Ubenimex may be a treatment or adjuvant therapy for ovarian cancer, and its therapeutic effect can be enhanced in combination with AKT inhibitor.

Key words: Ovarian cancer, Ubenimex, Proliferation, Invasion, Apoptosis, Autophagy

CLC Number: 

  • R737.31
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Jin H, Yu Y, Zhang T, et al. Snail is critical for tumor growth and metastasis of ovarian carcinoma[J]. Int J Cancer, 2010, 126(9): 2102-2111.
[3] Cannistra SA. Cancer of the ovary[J]. New Engl J Med, 2004, 351(24): 2519-2529.
[4] Ffrench B, Gasch C, O’Leary JJ, et al. Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention[J]. Mol Cancer, 2014, 13: 262. doi: 10.1186/1476-4598-13-262.
[5] Liu S, Xie F, Wang H, et al. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated[J]. Oncol Rep, 2015, 33(3): 1372-1380.
[6] Hitzerd SM, verbrugge SE, Ossenkoppele G, et al. Positioning of aminopeptidase inhibitors in next generation cancer therapy[J]. Amino Acids, 2014, 46(4): 793-808.
[7] Wickstr(¨overo)m M, Larsson R, Nygren P, et al. Aminopeptidase N(CD13)as a target for cancer chemotherapy[J]. Cancer Sci, 2011, 102(3): 501-508.
[8] Wakita A, Ohtake S, Takada S, et al. Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study[J]. Int J Hematol, 2012, 96(1): 84-93.
[9] Ichinose Y, Genka K, Koike T, et al. NK421 Lung Cancer Surgery Group: randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma[J]. J Natl Cancer Inst, 2003, 95(8): 605-610.
[10] Xu JW, Li CG, Huang XE, et al. Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases[J]. Asian Pac J Cancer Prev, 2011, 12(4): 985-987.
[11] Tsukamoto H, Shibata K, Kajiyama H, et al. Aminopeptidase N(APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer[J]. BMC Cancer, 2008, 8:74. doi: 10.1186/1471-2407-8-74.
[12] Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1): W98-W102.
[13] Terauchi M, Kajiyama H, Shibata K, et al. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells[J]. BMC Cancer, 2007, 7: 140.
[14] 路金枝,陈爱平.顺铂联合乌苯美司对卵巢癌SKOV3细胞体外生长的作用[J].山东医药, 2012, 52(25): 50-52.
[15] Wang X, Liu Y, Wu R, et al. Role of ubenimex as an anticancer drug and its synergistic effect with akt inhibitor in human A375 and A2058 cells[J]. Onco Targets Ther, 2018, 11: 943-953. doi: 10.2147/OTT.S157480.
[16] Aozuka Y, Koizumi K, Saitoh Y, et al. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice[J]. Cancer Lett, 2004, 216(1): 35-42.
[17] Ishii K, Usui S, Sugimura Y, et al. Inhibition of aminopeptidase N(AP-N)and urokinase-type plasminogen activator(uPA)by zinc suppresses the invasion activity in human urological cancer cells[J]. Biol Pharm Bull, 2001, 24(3): 226-230.
[18] Malaguarnera L. Implication of apoptosis regulation in tumorigenesis[J]. Cancer Metastasis Rev, 2004, 23(3-4): 367-387.
[19] Han L, Zhang Y, Liu S, et al. Autophagy flux inhibition, G2/M cell cycle arrest and apoptosis induction by ubenimex in glioma cell lines[J]. Oncotarget, 2017, 8(64): 107730-107743.
[20] Klionsky DJ. Autophagy from phenomenology to molecular understanding in less than a decade[J]. Nat Rev Mol Cell Biol, 2007, 8(11): 931-937.
[21] Eum KH, Lee M. Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-ras-transformed fibroblasts[J]. Mol Cell Biochem, 2011, 348(1-2): 61-68.
[22] Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research[J]. Cell, 2010, 140(3): 313-326.
[23] Han L, Zhao Q, Liang X, et al. Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells[J]. Oncotarget, 2017, 8(28): 45643-45655.
[24] Krajarng A, Chulasiri M, Watanapokasin R. Etlingera elatior Extract promotes cell death in B16 melanoma cells via down-regulation of ERK and Akt signaling pathways[J]. BMC Complement Altern Med, 2017, 17(1):415. doi: 10.1186/s12906-017-1921-y.
[25] Díaz M, González R, Plano D, et al. A diphenyldiselenide derivative induces autophagy via JNK in HTB-54 lung cancer cells[J]. J Cell Mol Med, 2018, 22(1): 289-301.
[26] Tang R, Xu X, Yang W, et al. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways[J]. Cancer Lett, 2016, 373(1): 77-87.
[27] Wu J, Hu G, Dong Y, et al. Matrine induces Akt/mTOR signalling inhibition-mediated autophagy and apoptosis in acute myeloid leukaemia cells[J]. J Cell Mol Med, 2017, 21(6): 1171-1181.
[28] Wang C, Zhang X, Teng Z, et al. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice[J]. Eur J Pharmacol, 2014, 740: 312-320. doi: 10.1016/j.ejphar.2014.06.051.
[1] WANG Wei, WANG Yi-Feng, ZHANG Ling-Mei, LIN Qiong-Yan, HUANG Ju. umorigenicity and invasion of side population in human ovarian epithelial cancer OVCAR3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 8-11.
[2] WANG Xiao-Lei, ZHANG Hai-Thao, ZHANG Hui, GUO Cheng-Hao. Protective effects of shuxuening injecta on vascular  endothelial  cell injury in vitro due to iodine excesses [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 38-.
[3] LU Xiang-Dong, YANG Wei, XU Guang-Meng, QU Yuan-Ming. Expression and role of PPAR-γin meningiomas and troglitazone induced meningiomas cell apoptosis in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 65-.
[4] ZHAO Ge, ZOU Cunhua, SONG Dongdong, ZHAO Shuping. Effects of tanshinone IIA on the proliferation and apoptosis of endometrial carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 53-58.
[5] ZHANG Zhenwei, LI Jia, CHEN Keming. IGF2BP2/m6A/ITGA5 signal axis regulates the proliferation and migration of renal clear cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 74-84.
[6] SUN Lina, DU Xiaoxiao, ZHANG Hongjuan, MENG Jinlai. Human leukocyte antigen-G promotes trophoblast invasion by regulating decidual natural killer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 41-45.
[7] LIU Min, ZHANG Yuchao, MA Xiaoli, LIU Xinyu, SUN Lu, ZUO Dan, LIU Yuantao. Effects of orphan nuclear receptor NR4A1 on H2O2 induced injury of mouse renal podocytes [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 16-21.
[8] SHEN Xiaochang, SUN Yiqing, YAN Lei, ZHAO Xingbo. Expression of aryl hydrocarbon receptor nuclear translocator-like 2 in endometrial cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 74-80.
[9] CHEN Zhaobo, FANG Min, XUE Haoran, LIU Chunyan. Deubiquitinase USP35 promotes the cells migration and invasion of non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 30-37.
[10] ZHONG Lili, SHENG Ying, GUO Jianghong, YANG Shuangjian, HE Yijing. LncRNA-UCA1 effects invasion and metastasis of trophoblast cells by targeting miR-182-5p [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 76-82.
[11] ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95.
[12] SONG Tian, FU Linlin, WANG Qiumin, YANG Xiao, WANG Ying, BIAN Yuehong, SHI Yuhua. Expression of fatty acid transport protein 1 in granulosa cells of patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 22-26.
[13] LI Hui, JIANG Chaoyang, LIU Yan, ZHANG Man. Effects and mechanism of histone deacetylase SIRT1 controlled macrophage apoptosis induced by oxidized low density lipoprotein [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 6-12.
[14] Chunfang HA,Ruyue LI. Research progress of drug resistance in ovarian cancer and targeted therapy strategy [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 117-123.
[15] XU Bing, LI Yong, LIU Ming, LIU Yonghui. Silencing PRRX1 gene expression enhances the sensitivity of prostate cancer resistant cell line PC-3/DTX to docetaxel [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 103-110.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd